Celator Pharmaceuticals Company Profile (NASDAQ:CPXX)

About Celator Pharmaceuticals

Celator Pharmaceuticals logoCelator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's product, VYXEOS, a nano-scale liposomal formulation of cytarabine:daunorubicin, in Phase III clinical testing for the treatment of acute myeloid leukemia. The Company also conducted clinical development efforts on CPX-1, a nano-scale liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer; and has a preclinical stage product candidate CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation. The Company operates in the United States and Canada.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CPXX
  • CUSIP:
Key Metrics:
  • Previous Close: $30.24
  • 50 Day Moving Average: $28.68
  • 200 Day Moving Average: $12.63
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -91.64
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 7.09
Additional Links:
Companies Related to Celator Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Celator Pharmaceuticals (NASDAQ:CPXX) (?)
Ratings Breakdown: 4 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $21.20 (29.89% downside)

Analysts' Ratings History for Celator Pharmaceuticals (NASDAQ:CPXX)
Show:
DateFirmActionRatingPrice TargetDetails
6/1/2016Janney Montgomery ScottDowngradeBuy -> NeutralView Rating Details
6/1/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
5/31/2016Needham & Company LLCDowngradeBuy -> HoldView Rating Details
5/31/2016Roth CapitalDowngradeBuy -> Neutral$30.25 -> $26.00View Rating Details
3/15/2016HC WainwrightBoost Price TargetBuy$20.00View Rating Details
10/30/2015FBR & CoReiterated RatingOutperformView Rating Details
8/12/2015MLV & Co.Reiterated RatingBuy$6.00View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Celator Pharmaceuticals (NASDAQ:CPXX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016        
5/10/2016Q116($0.15)($0.16)ViewListenView Earnings Details
3/21/2016Q4($0.12)($0.13)ViewN/AView Earnings Details
11/12/2015Q315($0.16)($0.15)ViewListenView Earnings Details
8/11/2015Q215($0.14)($0.15)ViewListenView Earnings Details
5/7/2015($0.14)($0.14)ViewN/AView Earnings Details
3/17/2015($0.16)($0.07)ViewN/AView Earnings Details
11/13/2014($0.21)($0.21)ViewN/AView Earnings Details
8/11/2014($0.20)($0.18)ViewN/AView Earnings Details
5/13/2014($0.24)($0.16)ViewN/AView Earnings Details
3/24/2014Q4 13($0.15)($0.13)ViewN/AView Earnings Details
11/12/2013($0.20)($0.14)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Celator Pharmaceuticals (NASDAQ:CPXX)
Current Year EPS Consensus Estimate: $-0.60 EPS
Next Year EPS Consensus Estimate: $-0.33 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.15)($0.15)($0.15)
Q2 20162($0.15)($0.14)($0.15)
Q3 20162($0.16)($0.14)($0.15)
Q4 20162($0.18)($0.13)($0.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Celator Pharmaceuticals (NASDAQ:CPXX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Celator Pharmaceuticals (NASDAQ:CPXX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/3/2015Scott D MorensteinDirectorBuy5,000$1.87$9,350.00View SEC Filing  
10/6/2015Scott Thomas JacksonCEOBuy14,450$1.74$25,143.00View SEC Filing  
10/5/2015Fred M PowellCFOBuy13,700$1.78$24,386.00View SEC Filing  
10/1/2015Life Sciences Gp Ll Valence IIinsiderBuy12,200$1.64$20,008.00View SEC Filing  
11/18/2014Fred M PowellCFOBuy6,000$2.20$13,200.00View SEC Filing  
11/18/2014Michael R DoughertyDirectorBuy20,000$2.15$43,000.00View SEC Filing  
11/18/2014Scott Thomas JacksonCEOBuy10,000$2.20$22,000.00View SEC Filing  
5/15/2014Fred M PowellCFOBuy2,500$2.50$6,250.00View SEC Filing  
12/17/2013Fred M PowellCFOBuy2,500$3.50$8,750.00View SEC Filing  
12/17/2013Scott Thomas JacksonCEOBuy3,000$3.50$10,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Celator Pharmaceuticals (NASDAQ:CPXX)
DateHeadline
News IconCelator Pharmaceuticals (CPXX) – Analysts' Recent Ratings Updates - DailyQuint (NASDAQ:CPXX)
dailyquint.com - September 21 at 8:37 AM
News IconAnalysts Place Celator Pharmaceuticals Inc. (NASDAQ:CPXX) Under the Lens of the Microscope - Post News (NASDAQ:CPXX)
www.kentuckypostnews.com - September 13 at 9:15 AM
News IconCrowd Ratings & Broker Views on Celator Pharmaceuticals Inc. (NASDAQ:CPXX)? - Post News (NASDAQ:CPXX)
www.kentuckypostnews.com - August 29 at 9:37 PM
News IconCelator Pharmaceuticals Inc. (NASDAQ:CPXX) Shares in Focus According to the Crowd & Analysts - Post News (NASDAQ:CPXX)
www.kentuckypostnews.com - August 22 at 4:27 PM
insidermonkey.com logoRA Capital’s Top Q2 Performers; Predicts Big Things Ahead for Pharma Stocks (NASDAQ:CPXX)
www.insidermonkey.com - August 17 at 9:55 AM
prnewswire.com logoWith Impressive Data in Tow, Actinium Pharma An Overlooked ... - PR Newswire (press release) (NASDAQ:CPXX)
www.prnewswire.com - August 10 at 10:34 PM
ftsenews.co.uk logoNew Broker Ratings For Celator Pharmaceuticals Inc. (CPXX) - FTSE News (NASDAQ:CPXX)
www.ftsenews.co.uk - July 29 at 4:28 PM
marketexclusive.com logoMoleculin Biotech Inc (NASDAQ:MBRX): Proceed With Caution (NASDAQ:CPXX)
marketexclusive.com - July 27 at 12:29 PM
4-traders.com logoActinium: Another Promising Name in the AML Space (NASDAQ:CPXX)
www.4-traders.com - July 27 at 12:29 PM
News IconAre Analysts Bearish Celator Pharmaceuticals Inc (NASDAQ:CPXX) After Last Week? - Consumer Eagle (NASDAQ:CPXX)
www.consumereagle.com - July 20 at 11:43 PM
News IconCelator Pharmaceuticals Inc. (NASDAQ:CPXX): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:CPXX)
www.engelwooddaily.com - July 20 at 5:30 PM
News IconSolid Performer in Focus: Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) - Engelwood Daily (NASDAQ:CPXX)
www.engelwooddaily.com - July 19 at 9:43 PM
News IconInstitutional Investors Positive on Celator Pharmaceuticals Inc (NASDAQ:CPXX) - Press Telegraph (NASDAQ:CPXX)
presstelegraph.com - July 16 at 6:31 AM
News IconInvestor News: Lawsuit against Buyout of Celator Pharmaceuticals Inc (NASDAQ:CPXX) filed - GroundReport (NASDAQ:CPXX)
www.groundreport.com - July 15 at 10:19 AM
News IconInvestor News: Lawsuit against Buyout of Celator Pharmaceuticals Inc (NASDAQ:CPXX) filed (NASDAQ:CPXX)
www.groundreport.com - July 13 at 4:29 PM
marketrealist.com logoA Look at Jazz Pharmaceuticals’ Celator Acquisition Deal (NASDAQ:CPXX)
marketrealist.com - July 13 at 3:51 PM
marketrealist.com logoWhy Did Jazz Fall after Celator Acquisition Announcement? (NASDAQ:CPXX)
marketrealist.com - July 13 at 3:51 PM
News IconCelator Pharmaceuticals Inc. (NASDAQ:CPXX) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:CPXX)
www.engelwooddaily.com - July 13 at 11:46 AM
fiscalstandard.com logoBroker Outlook For Celator Pharmaceuticals Inc. (CPXX) - Fiscal Standard (NASDAQ:CPXX)
www.fiscalstandard.com - July 13 at 11:46 AM
news.cmlviz.com logoCelator Pharmaceuticals Inc Upside Stock Momentum at Extreme Strength - CML News (NASDAQ:CPXX)
news.cmlviz.com - July 12 at 4:29 PM
News IconAnalyst Target and Average Rating Watch: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) - Press Telegraph (NASDAQ:CPXX)
presstelegraph.com - July 12 at 4:29 PM
biz.yahoo.com logoCELATOR PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Completion of Acquisi (NASDAQ:CPXX)
biz.yahoo.com - July 12 at 4:02 PM
streetupdates.com logoAnalysts Reviewing Stocks: InspireMD, Inc. (NYSEMKT:NSPR) , Celator Pharmaceuticals Inc. (NASDAQ:CPXX) - Street Updates (NASDAQ:CPXX)
www.streetupdates.com - July 12 at 8:40 AM
streetinsider.com logoJazz Pharmaceuticals (JAZZ) Offers Results from Celator Pharma (CPXX) Tender Offer - StreetInsider.com (NASDAQ:CPXX)
www.streetinsider.com - July 12 at 8:40 AM
publicnow.com logoJazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celator Pharmaceuticals, Inc. (NASDAQ:CPXX)
www.publicnow.com - July 12 at 2:03 AM
News IconStock on the Rise for the Quarter: Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) - Engelwood Daily (NASDAQ:CPXX)
www.engelwooddaily.com - July 11 at 9:10 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For Celator Pharmaceuticals Inc. (CPXX) - Fiscal Standard (NASDAQ:CPXX)
www.fiscalstandard.com - July 10 at 4:12 PM
finance.yahoo.com logoSteven Cohen Hits Another Home Run in Oncology (NASDAQ:CPXX)
finance.yahoo.com - July 7 at 1:33 PM
News IconCan Celator Pharmaceuticals Inc. (NASDAQ:CPXX) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:CPXX)
www.engelwooddaily.com - July 6 at 10:10 PM
News IconCelator Pharmaceuticals Incorporated (NASDAQ:CPXX) Shorted Shares Decreased By 38.24% - Press Telegraph (NASDAQ:CPXX)
presstelegraph.com - July 5 at 4:21 PM
publicnow.com logoHercules Provides Portfolio Update for Q2 2016 and Highlights Con ... (NASDAQ:CPXX)
www.publicnow.com - July 5 at 12:01 PM
tradecalls.org logoShort Term Price Target on Celator Pharmaceuticals (CPXX) - Trade Calls (NASDAQ:CPXX)
www.tradecalls.org - July 1 at 4:23 PM
fiscalstandard.com logoRecently Issued Stock Ratings For Celator Pharmaceuticals Inc. (CPXX) - Fiscal Standard (NASDAQ:CPXX)
www.fiscalstandard.com - June 30 at 4:39 PM
News IconCelator Pharmaceuticals Incorporated (NASDAQ:CPXX) Short Interest Decreased By 38.24% - Press Telegraph (NASDAQ:CPXX)
presstelegraph.com - June 30 at 11:14 AM
News IconCovering the Bases on Celator Pharmaceuticals Inc. (NASDAQ:CPXX): Where is the Stock Going? - Press Telegraph (NASDAQ:CPXX)
presstelegraph.com - June 28 at 4:21 PM
News IconHow Many Celator Pharmaceuticals Inc (NASDAQ:CPXX)'s Analysts Are Bullish? - Press Telegraph (NASDAQ:CPXX)
presstelegraph.com - June 28 at 4:21 PM
fool.com logoWhy Celator Pharmaceuticals Is Up 1,610% in 2016 (NASDAQ:CPXX)
www.fool.com - June 27 at 8:21 AM
finance.yahoo.com logoJazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition (NASDAQ:CPXX)
finance.yahoo.com - June 27 at 12:09 AM
News IconShares Reaching Overbought Territory: Celator Pharmaceuticals, Inc. (NASDAQ:CPXX) - Press Telegraph (NASDAQ:CPXX)
presstelegraph.com - June 24 at 4:31 PM
tradecalls.org logoPrice Target Update on Celator Pharmaceuticals (NASDAQ:CPXX) - Trade Calls (NASDAQ:CPXX)
www.tradecalls.org - June 24 at 4:31 PM
fiscalstandard.com logoCelator Pharmaceuticals Inc. (CPXX) Current Analyst Ratings - Fiscal Standard (NASDAQ:CPXX)
www.fiscalstandard.com - June 23 at 3:48 PM
ftsenews.co.uk logoCelator Pharmaceuticals Inc. (CPXX) Updated Price Targets - FTSE News (NASDAQ:CPXX)
www.ftsenews.co.uk - June 23 at 3:48 PM
feeds.benzinga.com logoSlingshot Insights Hosts Informative Call On Moleculin Biotech: Here Are The Details (NASDAQ:CPXX)
feeds.benzinga.com - June 22 at 9:30 AM
fiscalstandard.com logoCelator Pharmaceuticals Inc. (CPXX) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:CPXX)
www.fiscalstandard.com - June 20 at 4:20 PM
streetupdates.com logoMost Recent Update on Price Moves: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , Acadia Healthcare Company ... - Street Updates (NASDAQ:CPXX)
www.streetupdates.com - June 17 at 4:14 PM
streetupdates.com logoStock's Price Moves: BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) , Celator Pharmaceuticals Inc. (NASDAQ:CPXX) - Street Updates (NASDAQ:CPXX)
www.streetupdates.com - June 15 at 9:07 AM
News IconCutting Edge Stocks in Focus- Celator Pharmaceuticals (NASDAQ:CPXX), Telefonaktiebolaget LM Ericsson (NASDAQ ... - Seneca Globe (NASDAQ:CPXX)
www.senecaglobe.com - June 15 at 9:07 AM
publicnow.com logoYale Joins PTX’s Phase 1b/2 AML Clinical Trial (NASDAQ:CPXX)
www.publicnow.com - June 14 at 10:09 PM
News IconHC Stocks Reports: Celator Pharmaceuticals Inc (NASDAQ:CPXX), Geron Corporation (NASDAQ:GERN) - share market updates (press release) (NASDAQ:CPXX)
sharemarketupdates.com - June 14 at 4:16 PM
News IconStocks Earnings Analysis Report: Celator Pharmaceuticals, Inc. (NASDAQ:CPXX), Digital Realty Trust Inc. (NYSE:DLR) - Beacon Chronicle (NASDAQ:CPXX)
www.beaconchronicle.com - June 14 at 4:16 PM

Social

Celator Pharmaceuticals (NASDAQ:CPXX) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff